A randomized controlled trial to evaluate efficacy and safety of early conversion to a low-dose calcineurin inhibitor combined with sirolimus in renal transplant patients

Abstract. Background:. The calcineurin inhibitor (CNI)-based immune maintenance regimen that is commonly used after renal transplantation has greatly improved early graft survival after transplantation; however, the long-term prognosis of grafts has not been significantly improved. The nephrotoxicit...

詳細記述

書誌詳細

出版年:	Chinese Medical Journal
主要な著者:	Xiang Zheng, Weijie Zhang, Hua Zhou, Ronghua Cao, Zhangfei Shou, Shuwei Zhang, Ying Cheng, Xuchun Chen, Chenguang Ding, Zuofu Tang, Ning Li, Shaohua Shi, Qiang Zhou, Qiuyuan Chen, Gang Chen, Zheng Chen, Peijun Zhou, Xiaopeng Hu, Xiaodong Zhang, Ning Na, Wei Wang, Yuanyuan Ji
フォーマット:	論文
言語:	英語
出版事項:	Wolters Kluwer 2022-07-01
オンライン･アクセス:	http://journals.lww.com/10.1097/CM9.0000000000001866